Home > ÇмúÇà»ç > ¿öÅ©¼¥

¿öÅ©¼¥
ÇÁ·Î±×·¥ ¾È³»
 2023 Genome Medicine Academy
 
 
³¯Â¥ ¼¼¼Ç Á¦¸ñ ½Ã°£ ¿¬»ç ¿¬»ç ¼Ò¼Ó ¹ßÇ¥ Á¦¸ñ
4¿ù 29ÀÏ(Åä) Àӻ󿬱¸¿¡ È°¿ë °¡´ÉÇÑ ÃֽŠÀ¯Àüü ±â¼ú
09:00-09:10 
(10')
¹Ú¿õ¾ç »ï¼º¼­¿ïº´¿ø Opening
09:10-09:50
(40')
±èÁ¤ÈÆ ¼­¿ï´ëÇб³ ÀÇ°ú´ëÇÐ Beyond Avante-garde in Medicine: In vivo Genome Editing for Vision
10:00-10:40
(40')
±è½ÃÇö ¼­¿ï´ëÇб³ ÀÇ°ú´ëÇÐ Clinical Cancer Genomics and Personalized Medicine
10:40-11:30
(40')
±èÇöÁ¦ ¼­¿ï´ëÇб³ ÀÇ°ú´ëÇÐ High resolution multiomics toolkits for translational research
6¿ù 3ÀÏ
(Åä)
À¯ÀüüºÐ¼®À» ÅëÇÑ ½Å°æ°èÁúȯ ¿¬±¸
09:00-09:40
(40')
ÀÌÁ¤È£ KAIST Somatic mosaicism in neurological disorders
09:40-10:20
(40')
ÀÓº´Âù ¼­¿ï´ëÇб³ ÀÇ°ú´ëÇÐ Exome and genome sequencing results in a large pediatric neurological disorders cohort
10:20-11:00
(40')
¹®Àå¼· ¼­¿ï´ëÇб³ ÀÇ°ú´ëÇÐ Genomic medicine for adult neurological disorders
6¿ù 24ÀÏ
(Åä)
À¯ÀüüºÐ¼®À» ÅëÇÑ ½ÉÀå Áúȯ ¿¬±¸
09:00-09:30
(30')
¿ÀÀç¿ø ¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ TBD
09:30-10:10
(40')
±è»ó¿ì ¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ Whole-genome sequencing for identifiying pathogenic variants in cardiomyopathy 
10:10-10:50
(40')
À̽ÂÇö ¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ TBD
10:50-11:30
(40')
À̽ÂÇ¥ ¼­¿ï´ëÇб³ ÀÇ°ú´ëÇÐ Identifying high cardiovascular risk populations using polygenic risk scores
9¿ù 23ÀÏ
(Åä)
À¯ÀüüºÐ¼®À» ÅëÇÑ ¾ÏÁúȯ ¿¬±¸
09:00-09:30
(30')
Á¤½ÂÇö
°¡Å縯´ëÇб³
ÀÇ°ú´ëÇÐ
À¯Àüü ºÐ¼®À» È°¿ëÇÑ ¾ÏÁøÈ­ ¿¬±¸
09:30-10:00
(30')
ÃÖÀ±Áø ¼­¿ï¼º¸ðº´¿ø À¯Àüü ºÐ¼®À» È°¿ëÇÑ ºÎÀÎ¾Ï ¿¬±¸
10:10-10:30
(20')
À¯ÅÂ°æ ¾Æ»êº´¿ø ¾×ü»ý°ËÀ» È°¿ëÇÑ À¯¹æ¾Ï ¿¬±¸
10:30-11:00
(30')
±èÈ¿Áø ºÐ´ç¼­¿ï´ëº´¿ø º´¸®°Ëü¸¦ È°¿ëÇÑ ¾Ï À¯Àüü ¿¬±¸
11:10-11:40
(30')
ÇÑ¹Ì·É ÀÎõ´ëÇб³ Exome Sequencing Analysis in Clinical Research
10¿ù 28ÀÏ
(Åä)
À¯ÀüüºÐ¼®À» ÅëÇÑ ¹ÙÀÌ¿À¸¶Ä¿ ¹ß±¼°ú °ËÁõ ¿¬±¸
09:00-09:20
(20')
À±Àç¿ø º¸ÈÆÀÇÇבּ¸¼Ò Introduction and challenges of liquid biopsy-based biomarkers
09:20-10:00
(40')
À̽ÂÅ ¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ Discovering markers of cancer treatment response through genomic analysis
10:00-10:40
(40')
¼±ÃæÇö Áö³ð¿ÀÇǴϾð Association biomarker discovery of Clonal hematopoiesis of indeterminate potential (CHIP)  with target disease
10:40-11:20
(40')
ÇѵµÇö ¼­¿ï´ëÇк´¿ø Proteomics ±â¹ýÀ» ÀÌ¿ëÇÑ ´Ü¹éÁú ¹ÙÀÌ¿À¸¶Ä¿ ¹ß±¼ ¹× °ËÁõ
11¿ù 25ÀÏ
(Åä)
À¯ÀüüºÐ¼®À» ÅëÇÑ ÇǺÎÁúȯ ¿¬±¸
09:00-09:20
(20')
Á¤±âÈÆ ¼­¿ï´ëÇб³ ÀÇ°ú´ëÇÐ Introduction and exploration of immune cell diversity
09:20-10:00
(40')
¾çÇѽ½ KAIST À¯Àüü ºÐ¼®À» È°¿ëÇÑ ÇǺÎÁٱ⼼Æ÷ ±âÃÊ¿¬±¸
10:00-10:40
(40')
±èÅÂ±Õ ¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ Application of single-cell omics to identify targetable biomarkers in inflammatory skin diseases
10:40-11:20
(40')
½ÅÇöÅ ÀÎÇÏ´ëÇб³ ÀÇ°ú´ëÇÐ °ø°ø À¯Àüü µ¥ÀÌÅ͸¦ È°¿ëÇÑ ÇǺÎÁúȯ¿¬±¸
 

Çѱ¹À¯ÀüüÇÐȸ, [04501] ¼­¿ïƯº°½Ã Áß±¸ ¸¸¸®Àç·Î 193, 806È£(¸¸¸®µ¿1°¡, µð¿Àºô)
TEL : 02-558-9394 / FAX : 02-6956-9493 / E-mail : kogo@kogo.or.kr, »ç¾÷ÀÚµî·Ï¹øÈ£: 106-82-11801, ´ëÇ¥ÀÚ: ÀÌ¿¬¼ö
Copyright ¨Ï 2012 KOGO. All rights reserved.